Antares Pharma, Inc.

( )
ATRS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.03%540.111.0%$849.06m
DHRDanaher Corp. 0.00%251.710.7%$688.29m
ABTAbbott Laboratories -0.02%114.870.8%$658.91m
ISRGIntuitive Surgical, Inc. 0.31%224.000.8%$513.63m
MDTMedtronic Plc -0.88%98.700.6%$492.38m
ALGNAlign Technology, Inc. 2.97%283.006.4%$386.61m
BSXBoston Scientific Corp. 1.99%40.961.0%$385.08m
IDXXIDEXX Laboratories, Inc. 0.00%384.923.8%$360.98m
SYKStryker Corp. 0.00%234.941.3%$344.48m
EWEdwards Lifesciences Corp. -0.01%98.560.4%$316.81m
BDXBecton, Dickinson & Co. 0.23%252.501.0%$312.23m
DXCMDexCom, Inc. -2.72%273.007.7%$303.00m
AAgilent Technologies, Inc. 0.07%123.851.6%$263.19m
BAXBaxter International, Inc. 0.05%75.751.8%$248.71m
MTDMettler-Toledo International, Inc. 0.03%1258.895.8%$196.60m

Company Profile

Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.